東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Effects of steroid hormones on skele...

Tsai, Wan-Jung Alice.

FindBook

Google Book

Amazon

博客來

Effects of steroid hormones on skeletal muscle.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Effects of steroid hormones on skeletal muscle./
作者:	Tsai, Wan-Jung Alice.
面頁冊數:	273 p.
附註:	Adviser: Gayle A. Brazeau.
Contained By:	Dissertation Abstracts International68-12B.
標題:	Health Sciences, Pharmacology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3291513
ISBN:	9780549369592

Effects of steroid hormones on skeletal muscle.
Tsai, Wan-Jung Alice.

Effects of steroid hormones on skeletal muscle. - 273 p.

Adviser: Gayle A. Brazeau.

Thesis (Ph.D.)--State University of New York at Buffalo, 2007.

Steroid hormones are small lipophilic compounds synthesized from cholesterol and are important for numerous physiological and hormonal functions. This dissertation is focused on the effects of two types of steroid hormones, estrogens and glucocorticoids, on skeletal muscle. The first part of this dissertation investigates estrogen effects on skeletal muscle growth at the molecular level. Previous work suggested estrogen limits skeletal muscle growth in ovariectomized (OVX) rats. The underlying mechanisms were further investigated by monitoring specific muscle growth factors, myostatin and insulin-like growth factor-1 (IGF-1), following estrogen administration in the OVX rats. The mRNA and protein expression of both growth factors were measured at the end of 1 week or 5 weeks of treatments. Myostatin protein was found to increase with 1-week estrogen treatment only in the slow muscle (soleus, SOL), while IGF-1 protein was universally down-regulated by estrogen in the fast (extensor digitorum longus, EDL), slow, and mixed (gastrocnemius, GAS) muscles. Discordance between the mRNA and protein of both growth factors was observed. There was no treatment effect on IGF-1 and myostatin expression in the 5 week study suggesting a transient estrogen effect or up-regulation of a compensatory mechanism to counteract the estrogen effect observed at the earlier time point (1 week). The second part was to elucidate a better understanding of the potential underlying mechanism(s) of glucocorticoid-induced muscle atrophy. Gene array technology (Affymetrix) was employed to study multiple genes simultaneously. Glucocorticoid treatment was found to affect some of the ubiquitin-conjugases (E2 enzymes) and the ubiquitin-ligases (E3 enzymes) in the UPS pathway. A mechanism-based PK/PD modeling on the E3 enzymes, namely MuRF-1 and Atrogin-1, was conducted. The proposed model captured the acute data well; however, the model predicted an elevated expression throughout the chronic study and as such, did not capture the last time point (168 hour) where the gene expression had returned to the baseline. The results suggested the current understanding of the glucocorticoid receptor mechanism is not sufficient in describing the genomic response in skeletal muscle. A compensatory mechanism in addition to the down-regulation of the glucocorticoid receptor may exist and together they govern glucocorticoid resistance.

ISBN: 9780549369592Subjects--Topical Terms:

1017717
Health Sciences, Pharmacology.

Effects of steroid hormones on skeletal muscle.
LDR:03315nam 2200289 a 45 001 938965
005 20110512
008 110512s2007 eng d
020 $a 9780549369592
035 $a (UMI)AAI3291513
035 $a AAI3291513
040 $a UMI $c UMI
100 1 $a Tsai, Wan-Jung Alice. $3 1262942
245 1 0 $a Effects of steroid hormones on skeletal muscle.
300 $a 273 p.
500 $a Adviser: Gayle A. Brazeau.
500 $a Source: Dissertation Abstracts International, Volume: 68-12, Section: B, page: 7956.
502 $a Thesis (Ph.D.)--State University of New York at Buffalo, 2007.
520 $a Steroid hormones are small lipophilic compounds synthesized from cholesterol and are important for numerous physiological and hormonal functions. This dissertation is focused on the effects of two types of steroid hormones, estrogens and glucocorticoids, on skeletal muscle. The first part of this dissertation investigates estrogen effects on skeletal muscle growth at the molecular level. Previous work suggested estrogen limits skeletal muscle growth in ovariectomized (OVX) rats. The underlying mechanisms were further investigated by monitoring specific muscle growth factors, myostatin and insulin-like growth factor-1 (IGF-1), following estrogen administration in the OVX rats. The mRNA and protein expression of both growth factors were measured at the end of 1 week or 5 weeks of treatments. Myostatin protein was found to increase with 1-week estrogen treatment only in the slow muscle (soleus, SOL), while IGF-1 protein was universally down-regulated by estrogen in the fast (extensor digitorum longus, EDL), slow, and mixed (gastrocnemius, GAS) muscles. Discordance between the mRNA and protein of both growth factors was observed. There was no treatment effect on IGF-1 and myostatin expression in the 5 week study suggesting a transient estrogen effect or up-regulation of a compensatory mechanism to counteract the estrogen effect observed at the earlier time point (1 week). The second part was to elucidate a better understanding of the potential underlying mechanism(s) of glucocorticoid-induced muscle atrophy. Gene array technology (Affymetrix) was employed to study multiple genes simultaneously. Glucocorticoid treatment was found to affect some of the ubiquitin-conjugases (E2 enzymes) and the ubiquitin-ligases (E3 enzymes) in the UPS pathway. A mechanism-based PK/PD modeling on the E3 enzymes, namely MuRF-1 and Atrogin-1, was conducted. The proposed model captured the acute data well; however, the model predicted an elevated expression throughout the chronic study and as such, did not capture the last time point (168 hour) where the gene expression had returned to the baseline. The results suggested the current understanding of the glucocorticoid receptor mechanism is not sufficient in describing the genomic response in skeletal muscle. A compensatory mechanism in addition to the down-regulation of the glucocorticoid receptor may exist and together they govern glucocorticoid resistance.
590 $a School code: 0656.
650 4 $a Health Sciences, Pharmacology. $3 1017717
650 4 $a Health Sciences, Pharmacy. $3 1017737
650 4 $a Health Sciences, Toxicology. $3 1017752
690 $a 0383
690 $a 0419
690 $a 0572
710 2 0 $a State University of New York at Buffalo. $b Pharmaceutical Sciences. $3 1262923
773 0 $t Dissertation Abstracts International $g 68-12B.
790 $a 0656
790 1 0 $a Brazeau, Gayle A., $e advisor
791 $a Ph.D.
792 $a 2007
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3291513